VRAX viraxbiolabs.com: Expected earnings per share growth for next year

Public company logo of Virax Biolabs Group (VRAX)

The T-cell analysis ecosystem retains B2B clients through proprietary reagents but suffers from a post-pandemic exodus. Falling demand for virus diagnostics has crashed sales and free cash flow. The consensus estimate for net profit growth rates visualizes these trends, where the 0.00 metric reflects current dynamics. Meanwhile, portable laboratories allow Virax Biolabs Group (VRAX) to exercise pricing power due to the speed of primary tests.

VRAX: Virax Biolabs Group Ltd Consensus forecast of earnings per share growth for next year 04/28/2023 - 11/17/2026

Analytical breakdowns and data insights for company Virax Biolabs Group Ltd (VRAX)

- price and consensus price forecast:
General company analysis:Virax Biolabs Group
Finished products of Virax Biolabs Group Limited

Virax Biolabs Group (VRAX) maintains liquidity through the sale of diagnostic panels, which fully funds its current R&D research. By analyzing the trend of consensus EPS forecasts for the coming year, an investor assesses aggregated expert expectations for net cash flow over the next four quarters, allowing for a comparison of market optimism with the issuer's actual financial stability and fundamental ability to generate profit.

Competitor analysis for Virax Biolabs Group

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|XGN - Net earnings per share growth forecast for next year|MDxHealth Inc. - Projected earnings per share increase next year|LUCD: Earnings growth forecast for next year|Prenetics Global Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Corp (AIMD)|Earnings growth forecast for next year CODX (codiagnostics.com)|Heart Test Laboratories - Net earnings per share growth forecast for next year|Biomerica Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Cardio Diagnostics Holdings|ONCO (Onconetix Corporation) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year